Answers are grounded in this paper and cite their sources.
Introduction: RAS status is a predictive biomarker for anti-EGFR response in metastatic colorectal cancer (mCRC). The Idylla technology (IT) is a fully automated molecular testing system based on real-time PCR and provides rapid results in a very short preparation time. In this study, we aimed to evaluate the full RAS mutation status in Moroccan patients with mCRC.
No takes yet. Share an insight, caveat, or question.
Mounjid et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: